ORBIMED ADVISORS LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ORBIMED ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is a 10% Owner in CTI BIOPHARMA CORP ($CTIC) and a Director in GLAUKOS Corp ($GKOS) and a Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and a Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a in ACCELERON PHARMA INC ($XLRN) and a Director in ProNAi Therapeutics Inc ($DNAI) and a 10% Owner in AVEDRO INC ($AVDR) and a 10% Owner in Relypsa Inc ($RLYP) and a 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and a Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and a 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and a Director in SELECTA BIOSCIENCES INC ($SELB) and a Director in SI-BONE, Inc. ($SIBN) and a Director in Xtant Medical Holdings, Inc. ($XTNT) and a 10% Owner in Roka BioScience, Inc. ($ROKA) and a Director in Roka BioScience, Inc. ($ROKA) and a 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and a Director in Otonomy, Inc. ($OTIC) and a 10% Owner in Arsanis, Inc. ($ASNS) and a 10% Owner in Principia Biopharma Inc. ($PRNB) and a Director in Acutus Medical, Inc. ($AFIB) and a Director in SYNLOGIC, INC. ($MIRN) and a 10% Owner in NeuroPace Inc ($NPCE) and a 10% Owner in GRAYBUG VISION, INC. ($GRAY) and a 10% Owner in Sientra, Inc. ($SIEN) and a 10% Owner in TELA Bio, Inc. ($TELA) and a Director in Loxo Oncology, Inc. ($LOXO) and a 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and a Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and a Director in Dimension Therapeutics, Inc. ($DMTX) and a 10% Owner in Guardant Health, Inc. ($GH) and a 10% Owner in ViewRay, Inc. ($VRAY) and a Director in ViewRay, Inc. ($VRAY) and a Director in Turning Point Therapeutics, Inc. ($TPTX) and a in Tricida, Inc. ($TCDA) and a Director in Tricida, Inc. ($TCDA) and a 10% Owner in Inspire Medical Systems, Inc. ($INSP) and a Director in Inspire Medical Systems, Inc. ($INSP) and a Director in Synthorx, Inc. ($THOR) and a 10% Owner in scPharmaceuticals Inc. ($SCPH) and a Director in Adaptimmune Therapeutics PLC ($ADAP) and a Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and a Director in Corvus Pharmaceuticals, Inc. ($CRVS) and a 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and a Director in Audentes Therapeutics, Inc. ($BOLD) and a 10% Owner in SteadyMed Ltd. ($STDY) and a 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and a 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a Director in Intellia Therapeutics, Inc. ($NTLA) and a 10% Owner in Alector, Inc. ($ALEC) and a Director in Alector, Inc. ($ALEC) and a Director in Decibel Therapeutics, Inc. ($DBTX) and a Director in NextCure, Inc. ($NXTC) and a Director in LogicBio Therapeutics, Inc. ($LOGC) and a Director in Silverback Therapeutics, Inc. ($SBTX) and a Director in IMARA Inc. ($IMRA) and a Director in Keros Therapeutics, Inc. ($KROS) and a Director in Prelude Therapeutics Inc ($PRLD) and a Director in PMV Pharmaceuticals, Inc. ($PMVP) and a Director in ARMO BioSciences, Inc. ($ARMO) and a Director in resTORbio, Inc. ($TORC) and a Director in Prevail Therapeutics Inc. ($PRVL) and a 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and a Director in Edgewise Therapeutics, Inc. ($EWTX) and a Director in 89bio, Inc. ($ETNB) and a Director in Arcutis Biotherapeutics, Inc. ($ARQT) and a in Kinnate Biopharma Inc. ($KNTE) and a Director in Oric Pharmaceuticals, Inc. ($ORIC) and a Director in Repare Therapeutics Inc. ($RPTX) and a Director in Fusion Pharmaceuticals Inc. ($FUSN) and a Director in Terns Pharmaceuticals, Inc. ($TERN) and a Director in Ikena Oncology, Inc. ($IKNA).

Companies in which ORBIMED ADVISORS LLC is an Insider

89bio, Inc.

Trading Symbol: ETNB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,864,721 shares
Latest Transaction: Sep 23 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 16x
Sell: 2x
Shares Bought: 13,572,864
Shares Sold: 275,000
Share Difference: +13,297,864
Value Difference: -$45,900,000

ACCELERON PHARMA INC

Trading Symbol: XLRN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC:
Holdings: 576,889 shares
Current Value: $13,695,345
Latest Transaction: Sep 26 2013
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Acutus Medical, Inc.

Trading Symbol: AFIB
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 373,500 shares
Latest Transaction: Aug 12 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 5,477,958
Shares Sold: 0
Share Difference: +5,477,958
Value Difference: -$7,470,000

Adaptimmune Therapeutics PLC

Trading Symbol: ADAP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 4,902,910 shares
Current Value: $22,210,182
Latest Transaction: Jun 06 2018
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53

Last 4 weeks trend: SELL
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 7x
Shares Bought: 2,902,876
Shares Sold: 1,248,067
Share Difference: +1,654,809
Value Difference: -$8,092,736

Adicet Bio, Inc.

Trading Symbol: TORC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 5,243,259 shares
Latest Transaction: Feb 18 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 8x
Sell: 0x
Shares Bought: 11,373,188
Shares Sold: 0
Share Difference: +11,373,188
Value Difference: -$14,816,532

Aeglea BioTherapeutics, Inc.

Trading Symbol: AGLE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 1,390,724 shares
Current Value: $5,827,134
Latest Transaction: Feb 21 2017
$AGLE Market Capitalization: $56.54M
$AGLE Previous Close: $4.19

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 109,300
Shares Sold: 0
Share Difference: +109,300
Value Difference: -$563,882

Aerpio Pharmaceuticals, Inc.

Trading Symbol: ARPO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 21,400 shares
Latest Transaction: Dec 10 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 1x
Shares Bought: 1,561,895
Shares Sold: 21,400
Share Difference: +1,540,495
Value Difference: -$6,786,950

Alector, Inc.

Trading Symbol: ALEC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 6,002,771 shares
Latest Transaction: Apr 16 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 15x
Sell: 54x
Shares Bought: 13,094,029
Shares Sold: 6,457,042
Share Difference: +6,636,987
Value Difference: +$132,650,357

ALPINE IMMUNE SCIENCES, INC.

Trading Symbol: ALPN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 3,070,955 shares
Current Value: $7,186,035
Latest Transaction: Dec 30 2020
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 1x
Shares Bought: 3,670,955
Shares Sold: 600,000
Share Difference: +3,070,955
Value Difference: +$6,550,003

Arcutis Biotherapeutics, Inc.

Trading Symbol: ARQT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 4,267,564 shares
Latest Transaction: Oct 06 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 0x
Shares Bought: 5,169,850
Shares Sold: 0
Share Difference: +5,169,850
Value Difference: -$21,901,096

ARMO BioSciences, Inc.

Trading Symbol: ARMO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 3,709,356 shares
Latest Transaction: Jun 22 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 2x
Shares Bought: 4,118,903
Shares Sold: 4,118,903
Share Difference: 0
Value Difference: +$205,945,152

Audentes Therapeutics, Inc.

Trading Symbol: BOLD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 3,638,000 shares
Current Value: $57,589,540
Latest Transaction: Mar 12 2018
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 12x
Shares Bought: 4,582,400
Shares Sold: 1,266,641
Share Difference: +3,315,759
Value Difference: +$39,201,133

AVEDRO INC

Trading Symbol: AVDR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 3,523,204 shares
Latest Transaction: Feb 19 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 4,087,710
Shares Sold: 0
Share Difference: +4,087,710
Value Difference: $0

CONSTELLATION PHARMACEUTICALS INC

Trading Symbol: CNST
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 317,921 shares
Latest Transaction: Jul 24 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 835,842
Shares Sold: 0
Share Difference: +835,842
Value Difference: -$3,000,000

Corvus Pharmaceuticals, Inc.

Trading Symbol: CRVS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 8,053,298 shares
Current Value: $111,377,111
Latest Transaction: Feb 19 2021
$CRVS Market Capitalization: $293.59M
$CRVS Previous Close: $13.83

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 22x
Sell: 0x
Shares Bought: 8,053,298
Shares Sold: 0
Share Difference: +8,053,298
Value Difference: -$22,233,827

CTI BIOPHARMA CORP

Trading Symbol: CTIC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 7,520,600 shares
Current Value: $35,121,202
Latest Transaction: Jan 11 2021
$CTIC Market Capitalization: $129.36M
$CTIC Previous Close: $4.67

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 2x
Shares Bought: 5,000,000
Shares Sold: 4,000,000
Share Difference: +1,000,000
Value Difference: +$14,000,000

Decibel Therapeutics, Inc.

Trading Symbol: DBTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 2,732,106 shares
Latest Transaction: Feb 19 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 0x
Shares Bought: 4,945,192
Shares Sold: 0
Share Difference: +4,945,192
Value Difference: -$29,999,988

Dimension Therapeutics, Inc.

Trading Symbol: DMTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 5,397,698 shares
Current Value: $8,906,202
Latest Transaction: Oct 29 2015
$DMTX Market Capitalization: $41.32M
$DMTX Previous Close: $1.65

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Edgewise Therapeutics, Inc.

Trading Symbol: EWTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 13,046,956 shares
Latest Transaction: Mar 31 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 13,362,135
Shares Sold: 0
Share Difference: +13,362,135
Value Difference: -$5,750,000

Fusion Pharmaceuticals Inc.

Trading Symbol: FUSN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 2,224,770 shares
Latest Transaction: Jul 02 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 3,122,770
Shares Sold: 0
Share Difference: +3,122,770
Value Difference: -$15,266,000

GLAUKOS Corp

Trading Symbol: GKOS
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 562,839 shares
Current Value: $24,950,653
Latest Transaction: Mar 06 2018
$GKOS Market Capitalization: $1.51B
$GKOS Previous Close: $44.33

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 48x
Shares Bought: 0
Shares Sold: 2,897,948
Share Difference: -2,897,948
Value Difference: +$104,419,381

GRAYBUG VISION, INC.

Trading Symbol: GRAY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 562,500 shares
Latest Transaction: Sep 29 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 8,326,694
Shares Sold: 0
Share Difference: +8,326,694
Value Difference: -$18,000,000

Guardant Health, Inc.

Trading Symbol: GH
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 1,525,492 shares
Latest Transaction: Oct 11 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 1,534,464
Shares Sold: 0
Share Difference: +1,534,464
Value Difference: $0

Ikena Oncology, Inc.

Trading Symbol: IKNA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,816,425 shares
Latest Transaction: Apr 01 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 0x
Shares Bought: 7,523,197
Shares Sold: 0
Share Difference: +7,523,197
Value Difference: -$6,774,400

IMARA Inc.

Trading Symbol: IMRA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 937,500 shares
Latest Transaction: Mar 16 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 2,532,402
Shares Sold: 0
Share Difference: +2,532,402
Value Difference: -$15,000,000

Inspire Medical Systems, Inc.

Trading Symbol: INSP
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ORBIMED ADVISORS LLC: Director, 10% Owner
Holdings: 43,543 shares
Latest Transaction: Aug 19 2020

Last 4 weeks trend: SELL
Last 3 months trend: SELL View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 20x
Shares Bought: 2,444,221
Shares Sold: 2,444,421
Share Difference: -200
Value Difference: +$168,530,492

Intellia Therapeutics, Inc.

Trading Symbol: NTLA
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 2,662,180 shares
Current Value: $35,406,994
Latest Transaction: May 13 2016
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30

Last 4 weeks trend: HOLD
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 2,662,180
Shares Sold: 0
Share Difference: +2,662,180
Value Difference: -$4,500,000

INTERCEPT PHARMACEUTICALS, INC.

Trading Symbol: ICPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,120,609 shares
Current Value: $127,267,564
Latest Transaction: Jul 21 2015
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Kala Pharmaceuticals, Inc.

Trading Symbol: KALA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 3,422,840 shares
Latest Transaction: Feb 06 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 20x
Sell: 0x
Shares Bought: 3,603,173
Shares Sold: 0
Share Difference: +3,603,173
Value Difference: -$22,720,748

Keros Therapeutics, Inc.

Trading Symbol: KROS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 744,612 shares
Latest Transaction: Apr 13 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 1,268,734
Shares Sold: 0
Share Difference: +1,268,734
Value Difference: -$6,003,200

Kinnate Biopharma Inc.

Trading Symbol: KNTE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC:
Holdings: 543,494 shares
Latest Transaction: Dec 09 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 8x
Sell: 0x
Shares Bought: 3,847,929
Shares Sold: 0
Share Difference: +3,847,929
Value Difference: -$15,000,000

LogicBio Therapeutics, Inc.

Trading Symbol: LOGC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 3,524,997 shares
Latest Transaction: Oct 05 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 0x
Shares Bought: 7,948,265
Shares Sold: 0
Share Difference: +7,948,265
Value Difference: -$20,788,892

Loxo Oncology, Inc.

Trading Symbol: LOXO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 941,000 shares
Current Value: $37,357,700
Latest Transaction: Dec 12 2017
$LOXO Market Capitalization: $860.18M
$LOXO Previous Close: $39.70

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 8x
Shares Bought: 0
Shares Sold: 1,234,857
Share Difference: -1,234,857
Value Difference: +$72,775,613

NeuroPace Inc

Trading Symbol: NPCE
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 4,012,281 shares
Latest Transaction: Apr 26 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 4,247,281
Shares Sold: 0
Share Difference: +4,247,281
Value Difference: -$7,990,000

NextCure, Inc.

Trading Symbol: NXTC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 445,866 shares
Latest Transaction: May 13 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 0x
Shares Bought: 2,711,013
Shares Sold: 0
Share Difference: +2,711,013
Value Difference: -$5,250,000

Oric Pharmaceuticals, Inc.

Trading Symbol: ORIC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 2,240,440 shares
Latest Transaction: Mar 31 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 17x
Shares Bought: 2,765,717
Shares Sold: 665,444
Share Difference: +2,100,273
Value Difference: +$13,426,250

OTONOMY, INC.

Trading Symbol: OTIC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,850,094 shares
Current Value: $26,826,363
Latest Transaction: Nov 30 2015
$OTIC Market Capitalization: $442.34M
$OTIC Previous Close: $14.50

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PIERIS PHARMACEUTICALS, INC.

Trading Symbol: PIRS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 4,511,130 shares
Current Value: $9,924,486
Latest Transaction: May 02 2018
$PIRS Market Capitalization: $91.71M
$PIRS Previous Close: $2.20

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 30x
Sell: 6x
Shares Bought: 155,532
Shares Sold: 1,155,532
Share Difference: -1,000,000
Value Difference: +$6,916,712

PMV Pharmaceuticals, Inc.

Trading Symbol: PMVP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 475,000 shares
Latest Transaction: Sep 29 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 14x
Sell: 0x
Shares Bought: 14,128,660
Shares Sold: 0
Share Difference: +14,128,660
Value Difference: -$34,200,000

Prelude Therapeutics Inc

Trading Symbol: PRLD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 526,300 shares
Latest Transaction: Jan 12 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 9,569,579
Shares Sold: 0
Share Difference: +9,569,579
Value Difference: -$23,499,200

Prevail Therapeutics Inc.

Trading Symbol: PRVL
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 0 shares
Latest Transaction: Jan 26 2021

Last 4 weeks trend: SELL
Last 3 months trend: SELL View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 1x
Shares Bought: 11,392,463
Shares Sold: 13,822,463
Share Difference: -2,430,000
Value Difference: -$14,999,984

Principia Biopharma Inc.

Trading Symbol: PRNB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 1,605,713 shares
Latest Transaction: May 22 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 1x
Shares Bought: 2,605,713
Shares Sold: 1,000,000
Share Difference: +1,605,713
Value Difference: +$26,000,000

Relypsa Inc

Trading Symbol: RLYP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 3,700,000 shares
Latest Transaction: Jul 26 2016

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 2x
Shares Bought: 0
Shares Sold: 4,043,600
Share Difference: -4,043,600
Value Difference: +$129,388,328

Repare Therapeutics Inc.

Trading Symbol: RPTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 2,601,325 shares
Latest Transaction: Jun 25 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 3,375,525
Shares Sold: 0
Share Difference: +3,375,525
Value Difference: -$15,484,000

RESPONSE BIOMEDICAL CORP

Trading Symbol: RPBIF
Industry: SERVICES-TESTING LABORATORIES [8734]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 0 shares
Latest Transaction: Dec 01 2016

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 3x
Shares Bought: 892,858
Shares Sold: 5,788,459
Share Difference: -4,895,601
Value Difference: -$500,000

RHYTHM PHARMACEUTICALS, INC.

Trading Symbol: RYTM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 2,751,679 shares
Latest Transaction: May 24 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 4x
Shares Bought: 2,901,295
Shares Sold: 151,216
Share Difference: +2,750,079
Value Difference: -$1,373,792

scPharmaceuticals Inc.

Trading Symbol: SCPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 4,565,948 shares
Latest Transaction: May 26 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 0x
Shares Bought: 6,184,431
Shares Sold: 0
Share Difference: +6,184,431
Value Difference: -$35,666,658

SELECTA BIOSCIENCES INC

Trading Symbol: SELB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 12,193 shares
Latest Transaction: Jun 29 2016

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 8x
Sell: 0x
Shares Bought: 3,455,990
Shares Sold: 0
Share Difference: +3,455,990
Value Difference: -$15,400,000

SI-BONE, Inc.

Trading Symbol: SIBN
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 605,964 shares
Latest Transaction: Oct 19 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 985,368
Shares Sold: 0
Share Difference: +985,368
Value Difference: -$3,000,000

Sientra, Inc.

Trading Symbol: SIEN
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 17,100 shares
Current Value: $143,811
Latest Transaction: Oct 13 2015
$SIEN Market Capitalization: $156.38M
$SIEN Previous Close: $8.41

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Sierra Oncology, Inc.

Trading Symbol: SRRA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,477,320 shares
Latest Transaction: Jan 31 2020

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 1,477,320
Shares Sold: 0
Share Difference: +1,477,320
Value Difference: $0

Silverback Therapeutics, Inc.

Trading Symbol: SBTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 507,423 shares
Latest Transaction: Dec 08 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 20x
Sell: 0x
Shares Bought: 32,808,968
Shares Sold: 0
Share Difference: +32,808,968
Value Difference: -$100,000,064

Sorrento Tech, Inc.

Trading Symbol: ROKA
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 05 2017
$ROKA Market Capitalization: $8.04M
$ROKA Previous Close: $4.60

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 20x
Shares Bought: 0
Shares Sold: 893,470
Share Difference: -893,470
Value Difference: +$742,150

SpringWorks Therapeutics, Inc.

Trading Symbol: SWTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 6,078,103 shares
Latest Transaction: Sep 19 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 7,406,307
Shares Sold: 0
Share Difference: +7,406,307
Value Difference: -$4,950,000

SteadyMed Ltd.

Trading Symbol: STDY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 07 2018
$STDY Market Capitalization: $68.47M
$STDY Previous Close: $3.10

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 2x
Shares Bought: 1,174,000
Shares Sold: 4,246,196
Share Difference: -3,072,196
Value Difference: +$12,011,434

SYNLOGIC, INC.

Trading Symbol: SYBX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 3,696,662 shares
Current Value: $8,132,656
Latest Transaction: Apr 22 2021
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 2,381,666
Shares Sold: 0
Share Difference: +2,381,666
Value Difference: -$11,971,248

Synthorx, Inc.

Trading Symbol: THOR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,363,636 shares
Latest Transaction: Dec 13 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 5,316,355
Shares Sold: 0
Share Difference: +5,316,355
Value Difference: -$14,999,996

TELA Bio, Inc.

Trading Symbol: TELA
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 1,568,627 shares
Latest Transaction: Nov 13 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 0x
Shares Bought: 3,687,060
Shares Sold: 0
Share Difference: +3,687,060
Value Difference: -$9,999,990

Terns Pharmaceuticals, Inc.

Trading Symbol: TERN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,326,481 shares
Latest Transaction: Feb 09 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 3,791,204
Shares Sold: 0
Share Difference: +3,791,204
Value Difference: -$8,075,000

Tricida, Inc.

Trading Symbol: TCDA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 9,614,280 shares
Latest Transaction: Dec 12 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 21x
Sell: 1x
Shares Bought: 43,782,120
Shares Sold: 1,500,000
Share Difference: +42,282,120
Value Difference: +$23,900,004

Turning Point Therapeutics, Inc.

Trading Symbol: TPTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 1,120,730 shares
Latest Transaction: Apr 24 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 2,027,550
Shares Sold: 0
Share Difference: +2,027,550
Value Difference: -$6,480,000

ViewRay, Inc.

Trading Symbol: VRAY
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 7,464,378 shares
Current Value: $44,413,049
Latest Transaction: Aug 20 2018
$VRAY Market Capitalization: $257.35M
$VRAY Previous Close: $5.95

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 16x
Sell: 34x
Shares Bought: 1,651,807
Shares Sold: 3,615,067
Share Difference: -1,963,260
Value Difference: +$31,235,793

X4 Pharmaceuticals, Inc

Trading Symbol: ASNS
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 19,533 shares
Latest Transaction: Nov 20 2017

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 0x
Shares Bought: 1,868,966
Shares Sold: 0
Share Difference: +1,868,966
Value Difference: -$5,000,000

Xtant Medical Holdings, Inc.

Trading Symbol: XTNT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 53,468,376 shares
Current Value: $24,060,769
Latest Transaction: Nov 19 2020
$XTNT Market Capitalization: $5.29M
$XTNT Previous Close: $0.45

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 14x
Sell: 0x
Shares Bought: 13,960,261
Shares Sold: 0
Share Difference: +13,960,261
Value Difference: -$64,687,792

Latest Insider Trading Transactions of ORBIMED ADVISORS LLC

Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 26 2021NPCENeuroPace IncORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.003,605,38600
Apr 26 2021NPCENeuroPace IncORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.00171,89500
Apr 26 2021NPCENeuroPace IncORBIMED ADVISORS LLC10% OwnerBuyC0.003,777,28104,012,281235 K to 4 M (+1,607.35 %)
Apr 23 2021NPCENeuroPace IncORBIMED ADVISORS LLC10% OwnerBuyP17.00235,0003,995,000235,0000 to 235 K
Apr 23 2021NPCENeuroPace IncORBIMED ADVISORS LLC10% OwnerBuyP17.00235,0003,995,000235,0000 to 235 K
Apr 22 2021SYBXSYNLOGIC, INC.ORBIMED ADVISORS LLCDirectorGrantA3.001,666,6664,999,9983,696,6622 M to 3.7 M (+82.10 %)
Apr 01 2021IKNAIkena Oncology, In ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.0068,97800

View all ORBIMED ADVISORS LLC insider transactions.